Ventas enters this report on a strong operating run. In the second quarter, the Chicago-based REIT delivered normalized FFO of $0.97 per share, beating consensus by a penny, while revenue climbed 21.7% year over year to $1.73 billion. Growth has been powered by an aging U.S. population and rising healthcare spending, which continue to support demand for senior housing. A favorable supply backdrop and positive net move-ins have kept occupancy elevated. At the same time, the company has been reshaping its portfolio, accelerating senior-housing investments and raising its full-year 2026 acquisition target. This quarter will test whether that momentum is sustainable and whether management's recently raised guidance remains on track. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Consensus estimates point to year-over-year growth for the third quarter of 2026. Analysts expect normalized FFO of about $0.98 per share, up roughly 11% from $0.88 in the year-ago period, though the estimate has ticked down by a cent over the past week. Revenue is projected near $1.76–$1.77 billion, an increase of about 18%–19% from $1.49 billion a year earlier. Resident fees and services, the largest revenue line, are expected to rise from roughly $1.09 billion to about $1.39 billion. Key watch items include same-store SHOP occupancy and net move-ins, same-store cash NOI growth, and a projected decline in triple-net lease rental income to about $125 million from $160 million. Ventas raised its full-year 2026 normalized FFO guidance to $3.85–$3.90 per share last quarter, so investors will watch for any revision.
Sentiment heading into the report is broadly constructive but cautious. Ventas has beaten normalized FFO estimates in three of the past four quarters, and analyst ratings lean positive, with a consensus "Moderate Buy" and an average price target around $98–$100. Still, the stock has pulled back roughly 11% since its July earnings report, suggesting the market has already priced in much of the operating strength. Key risk factors include the expected decline in triple-net lease income as assets shift into SHOP or are sold, higher interest expense, and the potential for occupancy or pricing to fall short of lofty expectations. A larger-than-expected drop in NNN rental income or softer same-store metrics could pressure the stock.
Following this report, investors should focus on whether Ventas reaffirms or adjusts its full-year 2026 normalized FFO guidance of $3.85–$3.90 per share. Any change to that range will likely drive the immediate market response.
Demand signals in senior housing remain the central theme. Occupancy, net move-ins, and revenue per occupied room will indicate whether the company can keep expanding margins in its SHOP portfolio.
Cost and capital trends also matter. Interest expense and the pace of new acquisitions will shape both near-term earnings and balance-sheet leverage, which improved to 4.7 times net debt to adjusted EBITDA in the second quarter.
Finally, monitor the transition within the portfolio. As Ventas continues converting triple-net assets into operating properties and funding acquisitions with equity, the mix shift could temper near-term FFO even as it supports longer-term growth.
In my regular research workflow, I turn to Tickeron’s AI Screener to quickly scan healthcare REITs like Ventas for technical patterns, fundamentals, and sector comparisons. It helps surface relevant ideas and context without spending hours on manual filtering, which I find especially useful around earnings season.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for VTR moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VTR as a result. In 40 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for VTR turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 20 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for VTR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
VTR moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VTR crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in 204 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
VTR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. VTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.108) is normal, around the industry mean (3.134). VTR's P/E Ratio (161.364) is considerably higher than the industry average of (30.791). VTR's Projected Growth (PEG Ratio) (4.961) is slightly higher than the industry average of (1.649). Dividend Yield (0.023) settles around the average of (0.050) among similar stocks. P/S Ratio (6.605) is also within normal values, averaging (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines